Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELVN compared with NPCE: revenue, margins and what each company keeps, and the suppliers and customers both name
ELVN
Enliven Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
NPCE
NeuroPace Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELVN
Enliven Therapeutics, Inc.
vs
NPCE
NeuroPace Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ELVN, solid
NPCE, dashed
ELVN
Enliven Therapeutics, Inc.
Change
44.79
▲
+0.36%
· post 44.80
· delayed
Mkt cap
$3.3B
Revenue
—
Revenue
—
NPCE
NeuroPace Inc
Change
12.28
▼
−0.49%
· post 12.31
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$423.6M
Revenue
$23M
Q2 FY26
Revenue
$96M
FY25
vs
Compare
After hours
Nov 3 '26
delayed
ELVN
Enliven Therapeutics, Inc.
vs
NPCE
NeuroPace Inc
44.79
▲
+0.36%
post 44.80
delayed
Price
12.28
▼
−0.49%
post 12.31
delayed
$3.3B
Mkt cap
$423.6M
—
Revenue
$23M
Q2 FY26
—
Revenue
$96M
FY25
Change
Change
ELVN
44.79
▲
+0.36%
vs
NPCE
12.28
▼
−0.49%
After hours
Nov 3 '26
delayed